Legal & General Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26K | Hold |
7,216
| – | – | ﹤0.01% | 2898 |
|
|
2025
Q1 | $21.6K | Hold |
7,216
| – | – | ﹤0.01% | 2917 |
|
|
2024
Q4 | $24.2K | Hold |
7,216
| – | – | ﹤0.01% | 2961 |
|
|
2024
Q3 | $24.2K | Buy |
7,216
+1,172
| +19% | +$3.93K | ﹤0.01% | 2974 |
|
|
2024
Q2 | $20K | Hold |
6,044
| – | – | ﹤0.01% | 3016 |
|
|
2024
Q1 | $24.4K | Hold |
6,044
| – | – | ﹤0.01% | 2891 |
|
|
2023
Q4 | $18.4K | Hold |
6,044
| – | – | ﹤0.01% | 3066 |
|
|
2023
Q3 | $18.1K | Sell |
6,044
-1,071
| -15% | -$3.21K | ﹤0.01% | 3075 |
|
|
2023
Q2 | $26.6K | Sell |
7,115
-6,256
| -47% | -$23.4K | ﹤0.01% | 2989 |
|
|
2023
Q1 | $44.8K | Sell |
13,371
-15,880
| -54% | -$53.2K | ﹤0.01% | 2896 |
|
|
2022
Q4 | $141K | Hold |
29,251
| – | – | ﹤0.01% | 2725 |
|
|
2022
Q3 | $167K | Buy |
29,251
+744
| +3% | +$4.25K | ﹤0.01% | 2683 |
|
|
2022
Q2 | $203K | Buy |
28,507
+16,110
| +130% | +$115K | ﹤0.01% | 2623 |
|
|
2022
Q1 | $90K | Hold |
12,397
| – | – | ﹤0.01% | 2891 |
|
|
2021
Q4 | $111K | Hold |
12,397
| – | – | ﹤0.01% | 2888 |
|
|
2021
Q3 | $435K | Buy |
12,397
+4,317
| +53% | +$151K | ﹤0.01% | 2453 |
|
|
2021
Q2 | $174K | Buy |
8,080
+6,571
| +435% | +$142K | ﹤0.01% | 2571 |
|
|
2021
Q1 | $93K | Sell |
1,509
-31,821
| -95% | -$1.96M | ﹤0.01% | 2643 |
|
|
2020
Q4 | $1.39M | Buy |
+33,330
| New | +$1.39M | ﹤0.01% | 2019 |
|